Orlando (Fla.) Health recorded an operating income of $76.1 million (3% operating margin) in the first quarter of 2026, up from an operating income of $63.8 million (2.9% margin), according to its Feb. 20 financial report.
Total operating revenue was $2.5 billion for the three months ended Dec. 31, up from $2.2 billion during the same quarter last year. Net patient service revenue was $2.3 billion, up from $2 billion.
Total operating expenses were $2.4 billion for the quarter, up from $2.1 billion during the same period last year. Salaries and benefits totaled $1.3 billion, up from $1.1 billion. Supply costs totaled $584.1 million, up from $492.3 million.
Orlando Health said it has about $1.5 billion in construction projects in the works. Projects include $575 million earmarked for new bed towers, $217 million for medical pavilions and institutes and $157 million for freestanding emergency departments.
The health system reported a net income of $200.9 million in the first quarter, up from $9.2 million last year. Orlando Health said it recorded $115.9 million in investment income during the first quarter of 2026, compared to $57.3 million in investment losses during the same quarter last year.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
